Tokyo-based IDA Selects OmniComm's EDC Solution
OmniComm Systems, a global provider of clinical data management technology, announced its Promasys® EDC was selected by Integrated Development Associates.
OmniComm Systems, a global provider of clinical data management technology, announced its Promasys® EDC was selected by Integrated Development Associates (IDA), a Tokyo-based Pan Asian drug development company to run clinical trials in Japan and the Philippines. Japan represents the second largest pharmaceutical market in the world whereas the Philippines is one of the fastest growing markets. IDA selected Promasys to offer clients data management and EDC services, as well as its suitability for ease of use, fast study build, data quality and integrity and subject recruitment needs.
Read the full release here.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
